An experimental blood test has detected prostate cancer so accurately that it could supplant PSA levels as a screening mechanism for the disease, according to researchers.
Recent randomized trials have shown that following radical prostatectomy for prostate cancer, adjuvant radiotherapy improves progression-free survival (PFS). Nevertheless, it is possible that some patients with adverse pathological features may be appropriate candidates for delayed salvage radiotherapy.
Men who take finasteride or alpha blockers for BPH are at higher risk of prostate cancer than non-users, investigators in Finland conclude.
Contrary to what is commonly thought, the risk of having a positive repeat prostate biopsy is no lower for men with a fluctuating PSA level than it is for those with a steady or steadily increasing PSA level.